edoc

Items where Author is "Making Randomized Trials Affordable Group, "

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: Yes
Number of items: 4.

Yes

Taji Heravi, A. and Henn, A. and Deuster, S. and McLennan, S. and Gloy, V. and Mitter, V. R. and Briel, M. and Making Randomized Trials Affordable Group, . (2022) Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: a mixed-methods study. PLoS One, 17 (3). e0264427.

Speich, B. and Logullo, P. and Deuster, S. and Marian, I. R. and Moschandreas, J. and Taji Heravi, A. and Gloy, V. and Briel, M. and Hopewell, S. and Making Randomized Trials Affordable Group, . (2021) A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials. J Clin Epidemiol, 131. pp. 70-78.

Speich, Benjamin and von Niederhäusern, Belinda and Blum, Claudine Angela and Keiser, Jennifer and Schur, Nadine and Fürst, Thomas and Kasenda, Benjamin and Christ-Crain, Mirjam and Hemkens, Lars G. and Pauli-Magnus, Christiane and Schwenkglenks, Matthias and Briel, Matthias and Making Randomized Trials Affordable Group, . (2018) Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list. Journal of clinical epidemiology, 96. pp. 73-83.

Speich, Benjamin and von Niederhäusern, Belinda and Schur, Nadine and Hemkens, Lars G. and Fürst, Thomas and Bhatnagar, Neera and Alturki, Reem and Agarwal, Arnav and Kasenda, Benjamin and Pauli-Magnus, Christiane and Schwenkglenks, Matthias and Briel, Matthias and Making Randomized Trials Affordable Group, . (2018) Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data. Journal of clinical epidemiology, 96. pp. 1-11.

This list was generated on Fri Mar 29 09:20:14 2024 CET.